MedTrace Logo

Thalassemia Screening by Third Generation Sequencing

NCT05552690 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-08

No results posted yet for this study

Summary

Test globin gene in participants

Conditions

  • Thalassemia Trait
  • Thalassemia; Mixed

Interventions

PROCEDURE

blood draw

10 ml of blood will be draw to genetic analysis (sequencing)

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-04-30
Completion
2023-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05552690 on ClinicalTrials.gov